Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex

Journal of Child Neurology

Volumn 30, Issue 14, 2015, Pages 1954-1962

  Sundberg, Maria ^a   Sahin, Mustafa ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cerebellum; magnetic resonance imaging; mechanistic target of rapamycin; mouse models; Purkinje cell

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL MODEL; ARTICLE; AUTISM; CEREBELLUM; INTERPERSONAL COMMUNICATION; KNOCKOUT MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PURKINJE CELL; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; ANIMAL; AUTISM SPECTRUM DISORDER; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; AUTISM SPECTRUM DISORDER; CEREBELLUM; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS;

EID: 84947068923     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073815600870     Document Type: Article

References (115)

1. Kwiatkowski DJ, Whittemore VH, Thiele EA, eds. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. 1st ed. Weinheim, Germany: Wiley-VCH; 2010.
2. Crino PB, Nathanson KL, Henske EP,. The tuberous sclerosis complex. N Engl J Med. 2006; 355: 1345-1356.
3. Lipton JO, Sahin M,. The neurology of mTOR. Neuron. 2014; 84: 275-291.
4. Mizuguchi M, Takashima S,. Neuropathology of tuberous sclerosis. Brain Dev. 2001; 23: 508-515.
5. Goodman M, Lamm SH, Engel A, et al. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol. 1997; 12: 85-90.
6. Major P, Rakowski S, Simon MV, et al. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia. 2009; 50: 147-154.
7. Wong V, Khong PL,. Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities. J Child Neurol. 2006; 21: 99-105.
8. Numis AL, Major P, Montenegro MA, et al. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology. 2011; 76: 981-987.
9. Bolton PF, Park RJ, Higgins JN, et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002; 125 (pt 6): 1247-1255.
10. Kaczorowska M, Jurkiewicz E, Domanska-Pakiela D, et al. Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex. Epilepsia. 2011; 52: 22-27.
11. Wang S, Fallah A,. Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options. Neuropsychiatr Dis Treat. 2014; 10: 2021-2030.
12. Mohamed AR, Bailey CA, Freeman JL, et al. Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring. Neurology. 2012; 79: 2249-2257.
13. Kothare SV, Singh K, Chalifoux JR, et al. Severity of manifestations in tuberous sclerosis complex in relation to genotype. Epilepsia. 2014; 55: 1025-1029.
14. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001; 68: 64-80.
15. Jeste SS, Sahin M, Bolton P, et al. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol. 2008; 23: 520-525.
16. Wiznitzer M,. Autism and tuberous sclerosis. J Child Neurol. 2004; 19: 675-679.
17. Bauman ML, Kemper TL,. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci. 2005; 23: 183-187.
18. Casanova MF,. The neuropathology of autism. Brain Pathol. 2007; 17: 422-433.
19. Fatemi SH, Aldinger KA, Ashwood P, et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012; 11: 777-807.
20. Whitney ER, Kemper TL, Bauman ML, et al. Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28 k. Cerebellum. 2008; 7: 406-416.
21. Courchesne E, Yeung-Courchesne R, Press GA, et al. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988; 318: 1349-1354.
22. Amaral DG, Schumann CM, Nordahl CW,. Neuroanatomy of autism. Trends Neurosci. 2008; 31: 137-145.
23. Kates WR, Burnette CP, Eliez S, et al. Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism. Am J Psychiatry. 2004; 161: 539-546.
24. Akshoomoff N, Lord C, Lincoln AJ, et al. Outcome classification of preschool children with autism spectrum disorders using MRI brain measures. J Am Acad Child Adolesc Psychiatry. 2004; 43: 349-357.
25. Allen G, Courchesne E,. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry. 2003; 160: 262-273.
26. Limperopoulos C, Bassan H, Gauvreau K, et al. Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors? Pediatrics. 2007; 120: 584-593.
27. Limperopoulos C, Chilingaryan G, Guizard N, et al. Cerebellar injury in the premature infant is associated with impaired growth of specific cerebral regions. Pediatric Res. 2010; 68: 145-150.
28. Weber AM, Egelhoff JC, McKellop JM, et al. Autism and the cerebellum: evidence from tuberous sclerosis. J Autism Dev Disord. 2000; 30: 511-517.
29. Marti-Bonmati L, Menor F, Dosda R,. Tuberous sclerosis: differences between cerebral and cerebellar cortical tubers in a pediatric population. AJNR Am J Neuroradiol. 2000; 21: 557-560.
30. Ertan G, Arulrajah S, Tekes A, et al. Cerebellar abnormality in children and young adults with tuberous sclerosis complex: MR and diffusion weighted imaging findings. J Neuroradiol. 2010; 37: 231-238.
31. Menor F, Marti-Bonmati L, Mulas F, et al. Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients. Pediatr Radiol. 1992; 22: 485-489.
32. Vaughn J, Hagiwara M, Katz J, et al. MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort. AJNR Am J Neuroradiol. 2013; 34: 655-659.
33. Eluvathingal TJ, Behen ME, Chugani HT, et al. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol. 2006; 21: 846-851.
34. Asano E, Chugani DC, Muzik O, et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology. 2001; 57: 1269-1277.
35. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol. 1997; 42: 666-669.
36. Sillitoe RV, Joyner AL,. Morphology, molecular codes, and circuitry produce the three-dimensional complexity of the cerebellum. Annu Rev Cell Dev Biol. 2007; 23: 549-577.
37. Hatten ME, Heintz N,. Mechanisms of neural patterning and specification in the developing cerebellum. Annu Rev Neurosci. 1995; 18: 385-408.
38. Hatten ME,. Central nervous system neuronal migration. Annu Rev Neurosci. 1999; 22: 511-539.
39. Altman J, Bayer SA,. Embryonic development of the rat cerebellum. II. Translocation and regional distribution of the deep neurons. J Comp Neurol. 1985; 231: 27-41.
40. White JJ, Arancillo M, Stay TL, et al. Cerebellar zonal patterning relies on Purkinje cell neurotransmission. J Neurosci. 2014; 34: 8231-8245.
41. Martinez S, Crossley PH, Cobos I, et al. FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar development via a repressive effect on Otx2 expression. Development. 1999; 126: 1189-1200.
42. Yu T, Meiners LC, Danielsen K, et al. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. Elife. 2013; 2: e01305.
43. Crossley PH, Martinez S, Martin GR,. Midbrain development induced by FGF8 in the chick embryo. Nature. 1996; 380: 66-68.
44. Joyner AL,. Engrailed, Wnt and Pax genes regulate midbrain-hindbrain development. Trends Genet. 1996; 12: 15-20.
45. Thomas KR, Capecchi MR,. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature. 1990; 346: 847-850.
46. McMahon AP, Gavin BJ, Parr B, et al. The Wnt family of cell signalling molecules in postimplantation development of the mouse. Ciba Found Symp. 1992; 165199-165212; discussion 165212-165218.
47. Bally-Cuif L, Alvarado-Mallart RM, Darnell DK, et al. Relationship between Wnt-1 and En-2 expression domains during early development of normal and ectopic met-mesencephalon. Development. 1992; 115: 999-1009.
48. Millen KJ, Hui CC, Joyner AL,. A role for En-2 and other murine homologues of Drosophila segment polarity genes in regulating positional information in the developing cerebellum. Development. 1995; 121: 3935-3945.
49. Simeone A,. Positioning the isthmic organizer where Otx2 and Gbx2meet. Trends Genet. 2000; 16: 237-240.
50. Wilson SL, Kalinovsky A, Orvis GD, et al. Spatially restricted and developmentally dynamic expression of engrailed genes in multiple cerebellar cell types. Cerebellum. 2011; 10: 356-372.
51. Sillitoe RV, Vogel MW, Joyner AL,. Engrailed homeobox genes regulate establishment of the cerebellar afferent circuit map. J Neurosci. 2010; 30: 10015-10024.
52. Aruga J, Inoue T, Hoshino J, et al. Zic2 controls cerebellar development in cooperation with Zic1. J Neurosci. 2002; 22: 218-225.
53. Mizuhara E, Minaki Y, Nakatani T, et al. Purkinje cells originate from cerebellar ventricular zone progenitors positive for Neph3 and E-cadherin. Dev Biol. 2010; 338: 202-214.
54. Hoshino M, Nakamura S, Mori K, et al. Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron. 2005; 47: 201-213.
55. Muguruma K, Nishiyama A, Ono Y, et al. Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells. Nat Neurosci. 2010; 13: 1171-1180.
56. Nakatani T, Minaki Y, Kumai M, et al. The c-Ski family member and transcriptional regulator Corl2/Skor2 promotes early differentiation of cerebellar Purkinje cells. Dev Biol. 2014; 388: 68-80.
57. Minaki Y, Nakatani T, Mizuhara E, et al. Identification of a novel transcriptional corepressor, Corl2, as a cerebellar Purkinje cell-selective marker. Gene Expr Patterns. 2008; 8: 418-423.
58. Sillitoe RV, Gopal N, Joyner AL,. Embryonic origins of ZebrinII parasagittal stripes and establishment of topographic Purkinje cell projections. Neuroscience. 2009; 162: 574-588.
59. Whitney ER, Kemper TL, Rosene DL, et al. Calbindin-D28 k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment. J Neurosci Methods. 2008; 168: 42-47.
60. Lionel AC, Tammimies K, Vaags AK, et al. Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Hum Mol Genet. 2014; 23: 2752-2768.
61. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009; 459: 569-573.
62. Palmen SJ, van Engeland H,. Review on structural neuroimaging findings in autism. J Neural Transm. 2004; 111: 903-929.
63. DiCicco-Bloom E, Lord C, Zwaigenbaum L, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006; 26: 6897-6906.
64. Webb SJ, Sparks BF, Friedman SD, et al. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res. 2009; 172: 61-67.
65. Becker R, Stiemer B, Neumann L, et al. Mild ventriculomegaly, mild cerebellar hypoplasia and dysplastic choroid plexus as early prenatal signs of CHARGE association. Fetal Diagn Ther. 2001; 16: 280-283.
66. Sanlaville D, Verloes A,. CHARGE syndrome: an update. Eur J Hum Genet. 2007; 15: 389-399.
67. Aldinger KA, Kogan J, Kimonis V, et al. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. Am J Med Genet A. 2013; 161A: 131-136.
68. Bailey A, Luthert P, Dean A, et al. A clinicopathological study of autism. Brain. 1998; 121 (pt 5): 889-905.
69. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005; 57: 67-81.
70. Brito AR, Vasconcelos MM, Domingues RC, et al. Diffusion tensor imaging findings in school-aged autistic children. J Neuroimaging. 2009; 19: 337-343.
71. Sivaswamy L, Kumar A, Rajan D, et al. A diffusion tensor imaging study of the cerebellar pathways in children with autism spectrum disorder. J Child Neurol. 2010; 25: 1223-1231.
72. Aoki Y, Abe O, Nippashi Y, et al. Comparison of white matter integrity between autism spectrum disorder subjects and typically developing individuals: a meta-analysis of diffusion tensor imaging tractography studies. Mol Autism. 2013; 4: 25.
73. Schmitt LM, Cook EH, Sweeney JA, et al. Saccadic eye movement abnormalities in autism spectrum disorder indicate dysfunctions in cerebellum and brainstem. Mol Autism. 2014; 5: 47.
74. Schmahmann JD, Weilburg JB, Sherman JC,. The neuropsychiatry of the cerebellum-insights from the clinic. Cerebellum. 2007; 6: 254-267.
75. Stoodley CJ, Schmahmann JD,. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex. 2010; 46: 831-844.
76. Koziol LF, Budding D, Andreasen N, et al. Consensus paper: the cerebellum's role in movement and cognition. Cerebellum. 2014; 13: 151-177.
77. Marien P, Ackermann H, Adamaszek M, et al. Consensus paper: language and the cerebellum: an ongoing enigma. Cerebellum. 2014; 13: 386-410.
78. Deluca C, Golzar A, Santandrea E, et al. The cerebellum and visual perceptual learning: evidence from a motion extrapolation task. Cortex. 2014; 58: 52-71.
79. Bernardet M, Crusio WE,. Fmr1 KO mice as a possible model of autistic features. ScientificWorldJournal. 2006; 6: 1164-1176.
80. Hays SA, Huber KM, Gibson JR,. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J Neurosci. 2011; 31: 14223-14234.
81. Grossman AW, Aldridge GM, Lee KJ, et al. Developmental characteristics of dendritic spines in the dentate gyrus of Fmr1 knockout mice. Brain Res. 2010; 1355: 221-227.
82. Shahbazian MD, Orr HT, Zoghbi HY,. Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion. Neurobiol Dis. 2001; 8: 974-981.
83. Tsai PT, Hull C, Chu Y, et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature. 2012; 488: 647-651.
84. Reith RM, Way S, McKenna J III, et al. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Neurobiol Dis. 2011; 43: 113-122.
85. Reith RM, McKenna J, Wu H, et al. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol Dis. 2013; 51: 93-103.
86. Baudouin SJ, Gaudias J, Gerharz S, et al. Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science. 2012; 338: 128-132.
87. Han S, Tai C, Westenbroek RE, et al. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature. 2012; 489: 385-390.
88. Hadj-Sahraoui N, Frederic F, Delhaye-Bouchaud N, et al. Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. J Neurogenet. 1996; 11: 45-58.
89. Zhou J, Blundell J, Ogawa S, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci. 2009; 29: 1773-1783.
90. Argyropoulos A, Gilby KL, Hill-Yardin EL,. Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front Hum Neurosci. 2013; 7: 417.
91. Gharani N, Benayed R, Mancuso V, et al. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry. 2004; 9: 474-484.
92. Strick PL, Dum RP, Fiez JA,. Cerebellum and nonmotor function. Annu Rev Neurosci. 2009; 32: 413-434.
93. Dibble CC, Manning BD,. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol. 2013; 15: 555-564.
94. Zoncu R, Bar-Peled L, Efeyan A, et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 2011; 334: 678-683.
95. Laplante M, Sabatini DM,. mTOR signaling in growth control and disease. Cell. 2012; 149: 274-293.
96. Quevedo C, Salinas M, Alcazar A,. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells. Biochem Biophys Res Commun. 2002; 291: 560-566.
97. Takei N, Inamura N, Kawamura M, et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci. 2004; 24: 9760-9769.
98. Takei N, Kawamura M, Hara K, et al. Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J Biol Chem. 2001; 276: 42818-42825.
99. Di Nardo A, Wertz MH, Kwiatkowski E, et al. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1. Hum Mol Genet. 2014; 23: 3865-3874.
100. Di Nardo A, Kramvis I, Cho N, et al. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci. 2009; 29: 5926-5937.
101. Goto J, Talos DM, Klein P, et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci USA. 2011; 108: E1070-1079.
102. Choi YJ, Di Nardo A, Kramvis I, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008; 22: 2485-2495.
103. Zhang J, Kim J, Alexander A, et al. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol. 2013; 15: 1186-1196.
104. Yuan E, Tsai PT, Greene-Colozzi E, et al. Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. Hum Mol Genet. 2012; 21: 4286-4300.
105. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997; 277: 805-808.
106. Xu L, Sterner C, Maheshwar MM, et al. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics. 1995; 27: 475-480.
107. Li Y, Inoki K, Guan KL,. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol. 2004; 24: 7965-7975.
108. Inoki K, Li Y, Xu T, et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003; 17: 1829-1834.
109. Owonikoko TK, Khuri FR,. Targeting the PI3K/AKT/mTOR pathway: biomarkers of success and tribulation. Am Soc Clin Oncol Educ Book. 2013. doi:10.1200/EdBook-AM.2013.33.e395.
110. Yuan J, Mehta PP, Yin MJ, et al. PF-04691502, a potent and selective oral inhibitor of PI3 K and mTOR kinases with antitumor activity. Mol Cancer Ther. 2011; 10 (11): 2189-2199.
111. Takahashi K, Okita K, Nakagawa M, et al. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007; 2: 3081-3089.
112. Sivapatham R, Zeng X,. Generation and characterization of patient-specific induced pluripotent stem cell for disease modeling [published online ahead of print December 18, 2014]. Methods Mol Biol.
113. Prilutsky D, Palmer NP, Smedemark-Margulies N, et al. iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls. Trends Mol Med. 2014; 20: 91-104.
114. Merkle FT, Eggan K,. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell. 2013; 12: 656-668.
115. Chamberlain SJ, Chen PF, Ng KY, et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci USA. 2010;107: 17668-17673.